Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × sapanisertib × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other neoplasm 1 Lymphoid 1 Breast 1

Conditions

Malignant Neoplasms of Digestive Organs 1

Interventions

Surveys and Questionnaires 2 toripalimab 1 sapanisertib 1 iodixanol 1 durvalumab 1 daratumumab 1 abemaciclib 1 Yogurt 1 Tomography, Optical Coherence 1 Polyvinyl Alcohol 1 Medicine, Chinese Traditional 1 MLN 8237 1 Iodized Oil 1 Immunohistochemistry 1 Ethiodized Oil 1 Electrocardiography, Ambulatory 1 Celecoxib 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02812056 2017-03-27

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon ⚡